Lung cancer protein puzzle: scientists hunt for clues in tissue and blood
NCT ID NCT01647867
First seen Mar 17, 2026 · Last updated Jun 23, 2026 · Updated 19 times
Summary
This study examined Met receptor fragments in tissue and blood samples from 56 people with non-small cell lung cancer. Researchers used special lab tests to see which fragments are present and whether they are active. The goal was to learn more about the disease, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centre Hospitalier Régional et Universitaire
Lille, 59 037, France
-
Oscar Lambret Center
Lille, 59020, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help researchers better understand how Met receptor fragments relate to lung cancer, potentially guiding future treatments.
What could go wrong
This is an observational study with no treatment being tested. It is small (56 participants) and only looks at protein expression, so it may not lead to direct patient benefits.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.